NCT01928199View on ClinicalTrials.gov

Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2020

Study Completion Date

October 31, 2020

Conditions
Posttransplant Diabetes Mellitus
Interventions
DRUG

Sitagliptin

DRUG

Placebo

Trial Locations (1)

63110

Washington University, St Louis

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT01928199 - Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant | Biotech Hunter | Biotech Hunter